STK32C

Across TCGA pan-cancer cohorts, STK32C RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of STK32C’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where STK32C RNA is more highly expressed in tumor relative to normal tissue. In most cancer types STK32C is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

BLCA, COAD, and HNSC are the cancer types where STK32C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STK32C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	+1.135	<.001	12	view →
COAD	Male	IV	+1.551	<.001	10	view →
HNSC	Male	All	+0.764	<.001	9	view →
STAD	Male	II,III,IV	+1.539	<.001	8	view →
LIHC	Female	II,III,IV	+1.010	<.001	8	view →
KICH	Male	All	−1.744	<.001	6	view →
BRCA	All	All	+0.387	<.001	6	view →
THCA	Male	All	−0.368	<.001	4	view →
CHOL	All	All	+2.126	<.001	3	view →
ESCA	All	All	+1.455	<.001	3	view →
PRAD	All	All	+0.535	<.001	2	view →
LUSC	All	All	−0.344	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

STK32C–BLCA

Open the BLCA breakdown →